Global Microbiome Therapeutics Market Size study & Forecast, by Type (FMT, Microbiome Drugs), By Application (C. difficile, Crohn's Disease, Inflammatory Bowel Disease, Diabetes, Others) and Regional Analysis, 2022-2029

Description

List of Tables

Global Microbiome Therapeutics Market is valued approximately at USD 92.15 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 35.32% over the forecast period 2022-2029. Microbiome treatments aim to engineer the gut microbiome by applying native or synthetic bacteria, antibiotics, bacteriophages, and bacteriocins in additive, subtractive, or modulatory therapy. The market is expanding as a result of factors including the rise in strategic partnerships for R&D, product development, and portfolio expansion in the field of microbiome therapies. Most of the therapeutic drugs in development are still in their early stages, typically between Phase I and Phase II. Out of the 23, more than 13 medicines are being studied for GI indications, with the majority focusing on ulcerative colitis. For instance, Seres Therapeutics, Inc. disclosed SER-109 trial results from its Phase 3 ECOSPOR III study in 2021. It is planned to introduce the pipeline medicine in the first half of 2023 as an oral treatment for recurrent C. difficile infection. SER-109 is connected to a decrease in antimicrobial resistance genes as opposed to placebo. Also, a 4-year partnership for the development and discovery of microbial medicines was established in January 2022 between Hudson Institute and BiomeBank.

The demand for microbiome therapies is also rising as target diseases are becoming more prevalent. The development of microbiome research is anticipated to hunt for more effective cures for infections and other ailments, improving the results of medical therapy. Companies are bringing down the cost of their goods, increasing access to cutting-edge healthcare for a greater percentage of the population, and some countries' governing authorities are changing their strategies to support the adoption of microbiome-based treatments. As a result, this offers market vendors lucrative growth opportunities to increase their market share. The high cost of microbiome treatments and strict regulatory rules brought on by the product's complexity are the two main issues limiting the market's expansion.

The key regions considered for the Global Microbiome Therapeutics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. With the biggest market share in 2021, North America dominated the industry. The region's dominance is mostly due to its well-established research capabilities for the creation of innovative treatments and its expanding target population. Also, the ubiquity of initiatives like the Canadian Microbiome Initiative (CMI) in Canada makes it easier to work with partners and stakeholders. This makes it possible to concentrate research efforts on the creation of microbial medicines. For instance, the Biocodex Microbiota Foundation published a call for submissions in July 2021 for microbiome research funding totaling more than USD 26,000 in Canada. These incentives are anticipated to stimulate new market innovations. Asia Pacific is predicted to grow significantly during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for biosimilar development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market players included in this report are:

OpenBiome
Seres Therapeutics Inc.
4D Pharma plc.
Locus Biosciences, Inc.
Enterome SA
Finch Therapeutics Group, Inc.
Intralytix, Inc.
Microbiotica
Second Genome
Rebiotix Inc.

Recent Developments in the Market:

In December 2021, Kaleido Biosciences and Janssen have joined forces to explore the possibility of microbiome metabolic medicines for the treatment of immunological, atopic, and metabolic diseases that first appear in childhood.
in July 2021, The Biocodex Microbiota Foundation published a request for submissions for microbiome research funding totalling more than USD 26,000 in Canada. These incentives are anticipated to stimulate new market innovations.

Global Microbiome Therapeutics Market Report Scope:

Historical Data: 2019-2020-2021
Base Year for Estimation: 2021
Forecast period: 2022-2029
Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered: Type, Application, Region
Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Type:

FMT
Microbiome Drugs

By Application:

C. difficile
Crohn's Disease
Inflammatory Bowel Disease
Diabetes
Others

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Chapter 1. Executive Summary

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
- 1.2.1. Microbiome Therapeutics Market, by Region, 2019-2029 (USD Billion)
- 1.2.2. Microbiome Therapeutics Market, by Type, 2019-2029 (USD Billion)
- 1.2.3. Microbiome Therapeutics Market, by Application, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Microbiome Therapeutics Market Definition and Scope

2.1. Objective of the Study
2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Microbiome Therapeutics Market Dynamics

3.1. Microbiome Therapeutics Market Impact Analysis (2019-2029)
- 3.1.1. Market Drivers
  - 3.1.1.1. Increasing number of strategic collaborations for microbiome therapeutics for R&D
  - 3.1.1.2. Increase in the prevalence of target diseases.
- 3.1.2. Market Challenges
  - 3.1.2.1. High Cost of Microbiome Therapeutics
- 3.1.3. Market Opportunities
  - 3.1.3.1. Advancements in Formulation

Chapter 4. Global Microbiome Therapeutics Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Microbiome Therapeutics Market, by Type

6.1. Market Snapshot
6.2. Global Microbiome Therapeutics Market by Type, Performance - Potential Analysis
6.3. Global Microbiome Therapeutics Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
6.4. Microbiome Therapeutics Market, Sub Segment Analysis
- 6.4.1. FMT
- 6.4.2. Microbiome Drugs

Chapter 7. Global Microbiome Therapeutics Market, by Application

7.1. Market Snapshot
7.2. Global Microbiome Therapeutics Market by Application, Performance - Potential Analysis
7.3. Global Microbiome Therapeutics Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
7.4. Microbiome Therapeutics Market, Sub Segment Analysis
- 7.4.1. C. difficile
- 7.4.2. Crohn's Disease
- 7.4.3. Inflammatory Bowel Disease
- 7.4.4. Diabetes
- 7.4.5. Others

Chapter 8. Global Microbiome Therapeutics Market, Regional Analysis

8.1. Microbiome Therapeutics Market, Regional Market Snapshot
8.2. North America Microbiome Therapeutics Market
- 8.2.1. U.S. Microbiome Therapeutics Market
  - 8.2.1.1. Type breakdown estimates & forecasts, 2019-2029
  - 8.2.1.2. Application breakdown estimates & forecasts, 2019-2029
- 8.2.2. Canada Microbiome Therapeutics Market
8.3. Europe Microbiome Therapeutics Market Snapshot
- 8.3.1. U.K. Microbiome Therapeutics Market
- 8.3.2. Germany Microbiome Therapeutics Market
- 8.3.3. France Microbiome Therapeutics Market
- 8.3.4. Spain Microbiome Therapeutics Market
- 8.3.5. Italy Microbiome Therapeutics Market
- 8.3.6. Rest of Europe Microbiome Therapeutics Market
8.4. Asia-Pacific Microbiome Therapeutics Market Snapshot
- 8.4.1. China Microbiome Therapeutics Market
- 8.4.2. India Microbiome Therapeutics Market
- 8.4.3. Japan Microbiome Therapeutics Market
- 8.4.4. Australia Microbiome Therapeutics Market
- 8.4.5. South Korea Microbiome Therapeutics Market
- 8.4.6. Rest of Asia Pacific Microbiome Therapeutics Market
8.5. Latin America Microbiome Therapeutics Market Snapshot
- 8.5.1. Brazil Microbiome Therapeutics Market
- 8.5.2. Mexico Microbiome Therapeutics Market
8.6. Rest of The World Microbiome Therapeutics Market

Chapter 9. Competitive Intelligence

9.1. Top Market Strategies
9.2. Company Profiles
- 9.2.1. OpenBiome
  - 9.2.1.1. Key Information
  - 9.2.1.2. Overview
  - 9.2.1.3. Financial (Subject to Data Availability)
  - 9.2.1.4. Product Summary
  - 9.2.1.5. Recent Developments
- 9.2.2. Seres Therapeutics Inc.
- 9.2.3. 4D Pharma plc.
- 9.2.4. Locus Biosciences, Inc.
- 9.2.5. Enterome SA
- 9.2.6. Finch Therapeutics Group, Inc.
- 9.2.7. Intralytix, Inc.
- 9.2.8. Microbiotica
- 9.2.9. Second Genome
- 9.2.10. Rebiotix Inc.

Chapter 10. Research Process

10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

LIST OF TABLES

TABLE 1. Global Microbiome Therapeutics Market, report scope
TABLE 2. Global Microbiome Therapeutics Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Microbiome Therapeutics Market estimates & forecasts by Type 2019-2029 (USD Billion)
TABLE 4. Global Microbiome Therapeutics Market estimates & forecasts by Application 2019-2029 (USD Billion)
TABLE 5. Global Microbiome Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 6. Global Microbiome Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Microbiome Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Microbiome Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Microbiome Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Microbiome Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Microbiome Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Microbiome Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Microbiome Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Microbiome Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. U.S. Microbiome Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 17. U.S. Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. Canada Microbiome Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 19. Canada Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. UK Microbiome Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 22. UK Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. Germany Microbiome Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 25. Germany Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. France Microbiome Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 28. France Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. Italy Microbiome Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 31. Italy Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Spain Microbiome Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 34. Spain Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. RoE Microbiome Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 37. RoE Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. China Microbiome Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 40. China Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. India Microbiome Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 43. India Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. Japan Microbiome Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 46. Japan Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. South Korea Microbiome Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 49. South Korea Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. Australia Microbiome Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 52. Australia Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. RoAPAC Microbiome Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 55. RoAPAC Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. Brazil Microbiome Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 58. Brazil Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Mexico Microbiome Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 61. Mexico Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. RoLA Microbiome Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 64. RoLA Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. Row Microbiome Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 67. Row Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Microbiome Therapeutics Market
TABLE 70. List of primary sources, used in the study of global Microbiome Therapeutics Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

FIG 1. Global Microbiome Therapeutics Market, research methodology
FIG 2. Global Microbiome Therapeutics Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Microbiome Therapeutics Market, key trends 2021
FIG 5. Global Microbiome Therapeutics Market, growth prospects 2022-2029
FIG 6. Global Microbiome Therapeutics Market, porters 5 force model
FIG 7. Global Microbiome Therapeutics Market, pest analysis
FIG 8. Global Microbiome Therapeutics Market, value chain analysis
FIG 9. Global Microbiome Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Microbiome Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Microbiome Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Microbiome Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Microbiome Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Microbiome Therapeutics Market, regional snapshot 2019 & 2029
FIG 15. North America Microbiome Therapeutics Market 2019 & 2029 (USD Billion)
FIG 16. Europe Microbiome Therapeutics Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Microbiome Therapeutics Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Microbiome Therapeutics Market 2019 & 2029 (USD Billion)
FIG 19. Global Microbiome Therapeutics Market, company Market share analysis (2021)